Documento fuente o registro público

FDA 510(k) K242685 — Atellica® CH Creatinine_3 (Crea3)

FDA 510(k) index record K242685. Device: Atellica® CH Creatinine_3 (Crea3). Applicant as listed: Siemens Healthcare Diagnostics, Inc.. Decision date: 2024-12-04.

OtherU.S. Food and Drug Administration (FDA)2024-12-04

Fuente

"device_name": "Atellica® CH Creatinine_3 (Crea3)"

Esta entrada describe lo que cubre el documento; el propio documento es la autoridad. Incluirlo no implica estar de acuerdo con sus conclusiones.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K242685.

Device name: Atellica® CH Creatinine_3 (Crea3). Applicant as listed: Siemens Healthcare Diagnostics, Inc..

Decision date: 2024-12-04. Decision wording: Substantially Equivalent.

Product code: CGX. Regulation: 21 CFR 862.1225. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.

Explorar más